Attila Balog

Title: Attila Balog: Innovator in Inflammatory Disorder Biomarkers

Introduction

Attila Balog is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of medical research, particularly in the area of inflammatory disorders. His work focuses on innovative methods for determining susceptibility to these conditions.

Latest Patents

Attila Balog holds a patent for a method related to Methylene-tetrahydrofolate reductase isoform-based biomarkers. The patent, titled "Methylene-tetrahydrofolate reductase isoform-based biomarker and method of use thereof," addresses methods for determining a subject's susceptibility to developing inflammatory disorders. This invention also outlines treatment methods based on the subject's susceptibility. The patent highlights the importance of measuring expression levels of full-length MTHFR encoding mRNA and shortened MTHFR encoding mRNA initiated at intron 3 in cells from the subject. He has 1 patent to his name.

Career Highlights

Attila Balog is affiliated with Rush University Medical Center, where he continues to advance his research and innovations. His work has the potential to impact the diagnosis and treatment of inflammatory disorders significantly.

Collaborations

He collaborates with esteemed colleagues, including Tibor A Rauch and Timea Ocsko, who contribute to his research endeavors.

Conclusion

Attila Balog's innovative work in the field of inflammatory disorders showcases his dedication to advancing medical research. His contributions through patents and collaborations highlight the importance of innovation in healthcare.